Ligand Pharmaceuticals Free Cash Flow Analysis

Ligand Pharmaceuticals, Inc. (LGND)

204.56 +2.90 (+1.44%) USD | NASDAQ | Mar 25, 16:00

201.46 -3.10 (-1.52%) Pre-Market: 09:21

View Free Cash Flow for LGND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Free Cash Flow Chart

Start Trial

View Historical Data

Start Trial

View Free Cash Flow Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Free Cash Flow Benchmarks

Start Trial

Amicus Therapeutics, Inc.	29.85M
ADMA Biologics, Inc.	27.50M
Intuitive Surgical, Inc.	2.491B
Globus Medical, Inc.	579.02M
Establishment Labs Holdings, Inc.	-58.09M

Cash from Operations (Quarterly)	45.92M
Cash from Investing (Quarterly)	-18.10M
Cash from Financing (Quarterly)	8.33M
Free Cash Flow Per Share (Quarterly)	2.141
Free Cash Flow to Equity (Quarterly)	44.76M
Free Cash Flow to Firm (Quarterly)	46.66M
Free Cash Flow Yield	0.92%